Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real‐World" study. Issue 2 (25th November 2022) - Levi, Shai; Bronstein, Yotam; Goldschmidt, Neta; Morabito, Fortunato; Ziv‐Baran, Tomer; Del Poeta, Giovanni; Bairey, Osnat; Del Principe, Maria Ilaria; Fineman, Riva; Mauro, Francesca Romana; Gutwein, Odit; Reda, Gianluigi; et al.